{ "Exercise in Metastatic Breast Cancer: EMBody", "This study, called EMBody, is looking at how exercise affects people with metastatic breast cancer (cancer that has spread) that has not progressed in the last 12 months. Researchers want to see if a 16-week exercise program can improve your heart and lung fitness, physical abilities, and overall well-being. You could join if you are 18 or older, have metastatic breast cancer, and your disease hasn't gotten worse in the past year. The study aims to enroll up to 100 participants to compare the exercise program to usual care. The main goal is to see if exercise significantly improves your cardiorespiratory fitness (how well your heart and lungs work during exercise).", "design": "This is a randomized study with two groups, involving up to 100 participants. You would be randomly assigned to either the exercise program or usual care.", "commitments": "If you are in the exercise group, you will work with an exercise trainer three times a week for 16 weeks, with each session lasting 60 minutes. Your cardiorespiratory fitness will be measured at the beginning and after 16 weeks.", "compensation": "Not stated in the trial record.", "follow_up": "Your cardiorespiratory fitness will be measured at baseline and again after 16 weeks.", }

Study design

Not specified.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.